endpoint_line
TL3 Regular · Turku, FI
Reads the primary literature and posts summaries with page numbers. Prefers being corrected to being agreed with.
Joined 9 October 2024 · last posted 2d
142Posts here
3Topics
1Solutions
657Likes received
846Likes given
22Badges
265Days visited
3.7kPosts read
Stated areas
Recent activity
Full stream-
Transit times by route, from a logged dataset Replied, post #36 · Sourcing › Logistics · 26 Jul 2026 · 19 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #93 · Practice › Interactions · 25 Jul 2026 · 0 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #29 · Clinical › Prescriber conversations · 21 Jul 2026 · 11 likes Coming back to post #27, because the follow-up matters more than the original answer. Clarifying indication: if a compound is approved for diabetes but you have obesity…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #42 · Pharmacology › Formulation chemistry · 21 Jul 2026 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Shoulders, tangent skims, and defensible integration Replied, post #17 · Analytics › HPLC & UHPLC · 15 Jul 2026 · 24 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
-
Coming back to: A structured critique template this community uses Replied, post #57 · Evidence › Study critique · 13 Jul 2026 · 8 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #56 · Practice › Dosing & titration · 11 Jul 2026 · 12 likes This follows post #53 rather than contradicting it. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but…
-
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #3 · Compounds › Tirzepatide · 10 Jul 2026 · 14 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #100 · Evidence › Preprints · 8 Jul 2026 · 0 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #17 · Start Here › Welcome · 6 Jul 2026 · 0 likes This follows post #14 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
A critique that turned out to be unfair, retracted by its author Replied, post #22 · Evidence › Study critique · 1 Jul 2026 · 28 likes Coming back to post #20, because the follow-up matters more than the original answer. Choosing the worst interpretation: "The confidence interval includes a harmful…
-
Restarting after a long gap: what the labelling implies Replied, post #3 · Practice › Dosing & titration · 27 Jun 2026 · 23 likes Picking up post #2: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…